Vaccine Image Clock - Pixabay

Scientists and medical experts are racing to develop a vaccine to prevent SARS-CoV-2 (COVID-19). As some vaccine candidates are nearing the end of Phase III clinical trials, healthcare professionals are left with many questions. How were COVID-19 vaccines developed so quickly? When can we expect a COVID-19 vaccine? How can I be sure the vaccine is safe for me and my patients? Who should get the vaccine first?

October 29, 2020 ♦ 12 pm – 1 pm (CT)

Paul CarsonPaul Carson, MD, FACP, NDSU Professor of Practice and Medical Director of the NDSU Center for Immunization Research and Education, addresses these questions and more!

Upon completion of this program, participants will be able to:

  1. Describe the virology and epidemiology of the SARS-CoV-2 virus.
  2. Describe the development, licensure, approval, and possible distribution of the COVID-19 vaccine.
  3. Accurately and confidently address patient concerns with the COVID-19 vaccine.
  4. Describe North Dakota’s role in the pilot project to plan for distribution of the COVID-19 vaccine.

All healthcare professionals and the public are invited.  No registration is required and the program is free.

Join Zoom Meeting

 We want to hear from you! Please submit questions before the presentation to We will try to incorporate your questions into the presentation.

Unable to attend? A recording will be made available at a later date on the North Dakota Department of Health’s Immunization Program website. Continuing education credits will be available.

CME and CPE credits are being offered.